Evidence map›Paper›PMID 10559354›Full record

ArticleJournal of virology1999

Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.

M Aubert, J O'Toole, J A Blaho

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 136 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Antioxidants (Basel, Switzerland) · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M AubertDepartment of Microbiology, Mount Sinai School of Medicine, New York, New York 10029, USA.
J O'Toole
J A Blaho
Icahn School of Medicine at Mount Sinai · US

Funding

HSV REGULATION BY PROTEIN MODIFICATIONR01AI038873 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BLAHO, JOHN A. · 2002 to 2006
$1.5M
HSV REGULATION BY PROTEIN MODIFICATIONR21AI038873 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BLAHO, JOHN A. · 2001 to 2001
$339k
HSV PROTEIN NUCLEOTIDYLATION AND LYTIC INFECTIONR29AI038873 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BLAHO, JOHN A. · 1996 to 2000
$117k
NIAID NIH HHS AI38873NIAID NIH HHS R01 AI038873NIAID NIH HHS R21 AI038873NIAID NIH HHS R29 AI038873
6 · The paper itself

Abstract

Cultured human epithelial cells infected with an ICP27 deletion strain of herpes simplex virus type 1 (HSV-1) show characteristic features of apoptotic cells including cell shrinkage, nuclear condensation, and DNA fragmentation. These cells do not show such apoptotic features when infected with a wild-type virus unless the infections are performed in the presence of a protein synthesis inhibitor. Thus, both types of virus induce apoptosis, but the ICP27-null virus is unable to prevent this process from killing the cells. In this report, we show that this ICP27-deficient virus induced apoptosis in human HEp-2 cells through a pathway which involved the activation of caspase-3 and the processing of the death substrates DNA fragmentation factor and poly(ADP-ribose) polymerase. The induction of apoptosis by wild-type HSV-1 occurred prior to 6 h postinfection (hpi), and de novo viral protein synthesis was not required to induce the process. The ability of the virus to inhibit apoptosis was shown to be effective between 3 to 6 hpi. Wild-type HSV-1 infection was also able to block the apoptosis induced in cells by the addition of cycloheximide, staurosporine, and sorbitol. While U(S)3- and ICP22-deficient viruses showed a partial prevention of apoptosis, deletion of either the U(L)13 or vhs gene products did not affect the ability of HSV-1 to prevent apoptosis in infected cells. Finally, we demonstrate that in UV-inactivated viruses, viral binding and entry were not sufficient to induce apoptosis. Taken together, these results suggest that either gene expression or another RNA metabolic event likely plays a role in the induction of apoptosis in HSV-1-infected human cells.

Indexed as

ApoptosisAnimalsCaspase 3Caspase InhibitorsChlorocebus aethiopsEnzyme InhibitorsGene DeletionHerpesvirus 1, HumanHumansImmediate-Early ProteinsProtein KinasesProtein Serine-Threonine KinasesRibonucleasesSorbitolStaurosporineTime FactorsCASP3 protein, humanCaspase 3Caspase InhibitorsEnzyme InhibitorsEUS1 protein, Equine herpesvirus 1herpes simplex virus, type 1 protein ICP4ICP22 protein, human herpesvirus 1ICP27 protein, human herpesvirus 1Immediate-Early ProteinsProtein KinasesProtein Serine-Threonine KinasesRibonucleasesSorbitolStaurosporineUL13 protein, SimplexvirusUS3 protein, Human herpesvirus 1Viral ProteinsViral Regulatory and Accessory Proteinsvirion host shutoff protein, Simplexvirus

Identifiers

PMID10559354
PMCPMC113091
OpenAlexW1926535247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.